Governance
Investors

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions.

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

 

Sep 04 2026
, ,

Philogen is pleased to invite you to an upcoming webinar on September 25, 2026, at 14:00 GMT | 15:00 CET.

During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link or contact us at...
Aug 17 2026

Updated Phase III PIVOTAL Results for Nidlegy™ Published in the Journal of Clinical Oncology

Longer-term analysis confirms the clinical benefit of neoadjuvant Nidlegy™ in locally advanced, fully resectable melanoma The publication represents an update of the...
Jul 27 2026

Nidlegy™ Marketing Authorization Application Resubmitted to EMA

Siena, Italy, 27 July 2026 - Philogen S.p.A. (BIT:PHIL) is pleased to announce the submission of an updated Marketing Authorization Application (MAA) to the European...
May 21 2026
, ,

Deposito del Verbale dell’Assemblea degli Azionisti

More details
May 12 2026
, ,

Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al Primo Trimestre 2026

more details
May 12 2026
, ,

The Board of Directors approves the financial position for the first quarter of 2026 (Courtesy English Translation)

more detalis
May 06 2026
, ,

Philogen to attend the 74th American Society Mass Spectrometry annual conference in San Diego, May 31 – June 4 2026

Dr. Ettore Gilardoni will present a poster entitled "Mass Spectrometry–Based Atlas of the Blood-Accessible Surface Proteome in Syngeneic Brain Tumor Models". Follow the...
May 06 2026
, ,

Philogen to attend the Society of Nuclear Medicine and Molecular Imaging (SNMM) annual meeting on May 30 – June 2, 2026

Prof. Philipp Backhaus will give a presentation on “Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET and first experience with...
May 06 2026
, ,

Philogen to attend the Summer School in Pharmaceutical Analysis, 21-23 September 2026

Dr. Ettore Gilardoni is giving a lecture entitled "Mass Spectrometry Applications For Targets And Hit Compounds Identification". Follow the link for more details
May 06 2026
, ,

Philogen to attend the Festival of Biologics, 13-15 October 2026

Dr. Ettore Gilardoni will give an oral presentation entitled "Charge Variants characterization of a noncovalent dimeric fusion protein". Follow the link for more...

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions